Three-Arm Trial of Novel Treatment for Tinea Pedis
Status:
Completed
Trial end date:
2017-08-02
Target enrollment:
Participant gender:
Summary
This is a three-arm randomized controlled trial to assess the efficacy of an experimental
treatment in the treatment of tinea pedis (athlete's foot). The experimental treatment will
be tested against a vehicle control to determine efficacy and safety, and against an active
comparator to evaluate the success of the treatment relative to an existing gold-standard
treatment. Patients will be treated for four weeks, with their condition being assessed at
the end of treatment and two weeks after the end of treatment. The primary endpoint for this
study is effective treatment rate at the week 6 evaluation, defined as a mycological cure and
minimal clinical signs & symptoms. Secondary endpoints include safety and patient evaluation
of treatment.